European Pharmaceutical Contractor is available free on a controlled basis to strategic decision makers within the pharmaceutical contract market.
1. What is your Primary Field of Work/Business/Industry?
2. What is your Job Title?
Glycotope GMBH
Berlin, Germany – August 4, 2010 Glycotope GmbH, a leading glycobiology company, has received regulatory approval by German and Italian regulatory authorities for a Phase I study of Glycotope´s next generation antibody CetuGEX (GT-MAB 5.2-GEX) for the treatment of various solid cancers. More info >>
Evolution Summit 2010
27-29 October 2010, Montreux, Switzerland
Amidst attrition challenges and pressures from stakeholders, the laurels are up for grabs for the next leaders in drug development. While the industry is struggling to achieve financial sustainability and operational viability, it is awaiting the leadership of a new bold visionary who will bring fundamental innovation to overhauling the research approaches of the past. When gearing up for the future, pharmaceutical and biopharmaceutical companies continue securing long-lasting lucrative partnerships along their value chains. Incorporating novel development paradigms and improving internal decision-making pave the way to shorter timelines and growing profit margins. More info >>
